Is Galaxolide safe in cosmetics?
Galaxolide has a safety rating of "MODERATE" in our database. EU status: restricted. US status: permitted. 2 toxicological study endpoint(s) are available in our database.
Also known as: 1,3,4,6,7,8-hexahidro-4,6,6,7,8,8-hexametilindeno[5,6-c]pirano, 1,3,4,6,7,8-HEXAHYDRO-4,6,6,7,8,8- HEXAMETHYL CYCLOPENTA-γ-2-BENZOPYRAN, 1,3,4,6,7,8-HEXAHYDRO-4,6,6,7,8,8-HEXAMETHYL CYCLOPENTA-[g]-2-BENZOPYRAN, 1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclo-penta[g]-2-benzo pyrane, 1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopenta[g]-2-benzopyran (+11 more)
INCI: HEXAMETHYLINDANOPYRAN
Galaxolide (CAS 1222-05-5) is a cosmetic fragrance functioning as Fragrance fixative (polycyclic synthetic musk, sweet floral-musky scent). Reported NOAEL =30 mg/kg bw/day in Rabbit (ToxValDB_ECHA_IUCLID); EU Regulation 1223/2009 status: restricted, max Labeling required above 10 ppm leave-on / 100 ppm rinse-off. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in industrial chemical safety and pharmaceutical data.
View industrial chemical safety profile for CAS 1222-05-5 →
Galaxolide is classified GHS CMR hazard (H400, H410, H361) in the chemicals database but is restricted in EU cosmetics at max Labeling required above 10 ppm leave-on / 100 ppm rinse-off.
Source: Cosmetics: ingredients.eu_status/eu_max; Chemicals: ghs_classifications.signal_word/hazard_statement_code
For full compliance data across multiple jurisdictions, use the Substance Compliance tool.
Margin of Safety, dermal absorption, and sensitization profile summaries for Galaxolide.
Calculate MoS for your specific formulation with the MoS Calculator.
2 study endpoints found for Galaxolide. NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.
| Endpoint | Value | Route | Species | Study Type | Source |
|---|---|---|---|---|---|
| NOAEL | =30 mg/kg bw/day | oral | Rabbit | reproduction developmental | ToxValDB_ECHA_IUCLID |
| NOAEL | =300 mg/kg bw/day | oral | Rabbit | developmental | ToxValDB_ECHA_IUCLID |
Contact sensitization data for Galaxolide based on clinical patch test studies and IFRA standards.
Source: EU 2023/1545; SCCS/1459/11
10 toxicity values from EPA ToxValDB (aggregated from CCTE, HPV, ToxRefDB, IRIS, and other regulatory dossiers).
| Endpoint | Value | Species | Route | Duration | Source |
|---|---|---|---|---|---|
| LOAEL | =500 mg/kg-day | Rat | oral | short-term (developmental) | EPA TSCA 8e |
| LOAEL | =150 mg/kg-day | Rat | oral | short-term (developmental) | EPA TSCA 8e |
| LOAEL | =500 mg/kg-day | Rat | oral | short-term (developmental) | EPA TSCA 8e |
| NEL | =500 mg/kg-day | Rat | oral | short-term (developmental) | EPA TSCA 8e |
| NOAEL | =50 mg/kg-day | Rat | oral | short-term (developmental) | EPA TSCA 8e |
| NOAEL | =150 mg/kg-day | Rat | oral | short-term (developmental) | EPA TSCA 8e |
| LC50 | >5040 mg/m3 | Rat | inhalation | - | ECHA IUCLID |
| LD50 | >2000 mg/kg | Rat | dermal | acute | ECHA IUCLID |
| LD50 | >2000 mg/kg | Rat | oral | - | ECHA IUCLID |
| LOAEL | =30 mg/kg-day | Rabbit | oral | - | ECHA IUCLID |
Legally binding harmonized classification per Regulation (EC) No 1272/2008 (CLP) Annex VI.
Inserted via ATP: ATP01
1 human repeat insult patch test aggregated from dermatological literature.
| Test Type | N | Sensitized | Dose µg/cm² | NESIL µg/cm² | Potency |
|---|---|---|---|---|---|
| HMT | - | 0 | 9720 | - | - |
Cross-referenced EDC classifications, mechanism data, and dose-response evidence from EDLists, SIN List, and cosmetic-specific detail sources.
Source list: II
agonist (ERα); antagonist (AR, PR)
| Endpoint | Target | Value | Direction |
|---|---|---|---|
| ER binding/transcription; AR antagonism; PR antagonism | ER (ERa/ERb); AR; PR | EC50/IC50: PR antagonism IC50 ~20 nM; AR IC50 >1 uM; LOEC: 0.02 uM (PR antagonism); NOEC: 0.002 uM mixed | agonist ERa (weak); antagonist ERb; antagonist AR; antagonist PR |
| Progesterone, cortisol, androstenedione, E2, T secretion; 3bHSD2, CYP21 gene expression | steroidogenesis | EC50/IC50: Significant inhibition at >=10 uM in H295R; LOEC: 10 uM; NOEC: 1 uM mixed | inhibitor (downarrow progesterone, downarrow cortisol via downarrow 3bHSD2, downarrow CYP21) |
European Chemicals Agency REACH dossier and Substances of Very High Concern listing.
Additional regulatory detail beyond the 7-jurisdiction summary: Saudi SFDA, Korea MFDS, ASEAN ACD, Japan/Korea, Brazil/India, and cross-jurisdictional restriction entries.
| Jurisdiction | Status | Max % | Product Type |
|---|---|---|---|
| IN | banned | - | all cosmetics |
1 property record from structured ingredient metadata.
Safety and regulatory annotations from PubChem (NCBI) aggregated sources.
Expert safety assessment and concern-level summary for Galaxolide.
Public NOAEL study rows linked to Galaxolide by CAS number or substance name.
Same-CAS public records found in pharmaceutical data.
Same-CAS rows from the pharmaceutical spoke database.
Galaxolide has a safety rating of "MODERATE" in our database. EU status: restricted. US status: permitted. 2 toxicological study endpoint(s) are available in our database.
Galaxolide EU regulatory status: restricted. Maximum allowed concentration: Labeling required above 10 ppm leave-on / 100 ppm rinse-off. This is based on EU Regulation 1223/2009 and its amendments.
Galaxolide functions as: Fragrance fixative (polycyclic synthetic musk, sweet floral-musky scent). It is classified as a Fragrance in our database. CAS number: 1222-05-5.
The NOAEL (No Observed Adverse Effect Level) for Galaxolide is =30 mg/kg bw/day based on a reproduction developmental study via oral route in Rabbit. A total of 2 study endpoints are available. Source: ToxValDB_ECHA_IUCLID.
Galaxolide also appears in industrial chemical safety and pharmaceutical data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
Galaxolide is classified GHS CMR hazard (H400, H410, H361) in the chemicals database but is restricted in EU cosmetics at max Labeling required above 10 ppm leave-on / 100 ppm rinse-off.
Check Galaxolide compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.
Try Piro Free →Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Galaxolide in your formulation.